Harnessing Minimally Invasive Surgery to Improve Outcomes in Endometrial Cancer Surgery—The Robots Are Coming
Menée à partir de données de registres danois portant sur 5 654 patientes atteintes d'un cancer de l'endomètre de stade précoce, cette étude évalue l'association entre l'utilisation de techniques chirurgicales mini-invasives (chirurgie assistée par robot ou laparoscopique) et le risque de complications intra- ou post-opératoires sévères
Minimally invasive hysterectomy is now considered the standard of care for the treatment of women with early-stage endometrial care. Compared with laparotomy, minimally invasive surgery (MIS) is associated with fewer complications, shorter hospital stays, and equivalent long-term survival. Minimally invasive hysterectomy can be performed either laparoscopically or as a robotically assisted procedure. Although large randomized trials are lacking, most studies have found that significant morbidity and mortality are similar for robotically assisted and laparoscopic hysterectomy for endometrial cancer.3 However, compared with laparoscopic hysterectomy, robotically assisted surgery is significantly more costly owing to capital expenditures for the robot, disposable instrumentation, and increased operating room time.
Jama Surgery , résumé, 2018